Search Results - "Valpreda, Alessandra"
-
1
ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications
Published in Clinical and applied thrombosis/hemostasis (2022)“…The introduction Caplacizumab in the management of Immune thrombotic thrombocytopenic purpura (iTTP) has raised different questions, considering its…”
Get full text
Journal Article -
2
Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa
Published in Diagnostics (Basel) (01-08-2022)“…Recombinant porcine factor VIII (rpFVIII) is indicated for treating bleeding episodes in acquired haemophilia A, but there are few data regarding laboratory…”
Get full text
Journal Article -
3
Impact of COVID-19 Infection, Vaccination, and Serological Response in Immune Thrombocytopenic Purpura Patients: A Single-Center Global Analysis
Published in Biomedicines (23-10-2022)“…Both SARS-CoV-2 infection and vaccination have raised concern in immune-mediated diseases, including immune thrombocytopenic purpura (ITP) considering risk of…”
Get full text
Journal Article -
4
Extended half‐life rFIX in major surgery—How to improve clinical practice: An intraindividual comparison
Published in Clinical case reports (01-03-2020)“…Practical, safe, and effective hemostatic approach to orthopedic surgery using Extended Half‐Life factor IX in hemophilia B. By intraindividual comparison, we…”
Get full text
Journal Article -
5
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient
Published in Clinical case reports (01-01-2021)“…This case report highlights the challenges in controlling bleeding and correcting coagulation tests through the use of bypassing agents in patients with FV…”
Get full text
Journal Article -
6
Management of patients with bleeding disorders and educational needs regarding hemophilia a in 23 italian emergency departments - Results from a survey conducted in Piedmont
Published in Acta bio-medica : Atenei Parmensis (26-10-2022)“…Haemophilia and von Willebrand disease are the bleeding disorders most frequently encountered in the emergency department (ED), that are often the first point…”
Get full text
Journal Article -
7
Acquired haemophilia A and late development of secondary autoimmune disorders, evidences from a single-centre observational study
Published in Blood coagulation & fibrinolysis (01-10-2020)Get full text
Journal Article -
8
Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures
Published in European journal of gastroenterology & hepatology (01-11-2015)“…OBJECTIVESThe management of patients with liver cirrhosis undergoing invasive procedures is controversial and haemostasis assessment using routine laboratory…”
Get full text
Journal Article -
9
Inhibitory anti ADAMTS13 antibodies with a new rapid fully automated CLiA assay
Published in International journal of laboratory hematology (01-04-2021)“…Background Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening disorder characterized by severe ADAMTS13 deficiency. The acquired form is…”
Get full text
Journal Article -
10
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review
Published in Journal of clinical medicine (01-07-2023)“…Acquired hemophilia A (AHA) is a rare bleeding disease due to autoantibodies directed against clotting factor VIII (FVIII). Treatment of AHA consists of…”
Get full text
Journal Article -
11
Laboratory Aspirin Resistance Reversibility in Diabetic Patients: a Pilot Study Using Different Pharmaceutical Formulations
Published in Cardiovascular drugs and therapy (01-08-2014)“…Purpose Aspirin resistance occurs most frequently in diabetic patients and is associated with poor prognosis. The purpose of this study was to evaluate the…”
Get full text
Journal Article -
12
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review
Published in Journal of clinical medicine (10-07-2023)“…BACKGROUNDAcquired hemophilia A (AHA) is a rare bleeding disease due to autoantibodies directed against clotting factor VIII (FVIII). Treatment of AHA consists…”
Get full text
Report -
13
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient
Published in Clinical case reports (01-01-2021)“…This case report highlights the challenges in controlling bleeding and correcting coagulation tests through the use of bypassing agents in patients with FV…”
Get full text
Report -
14
Extended half-life rFIX in major surgery-How to improve clinical practice: An intraindividual comparison
Published in Clinical case reports (01-03-2020)“…Practical, safe, and effective hemostatic approach to orthopedic surgery using Extended Half-Life factor IX in hemophilia B. By intraindividual comparison, we…”
Get full text
Report